| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0009 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.18 | 0.001 |